Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Olmsted, Stuart S ^a,b   Khanna, Kristen V ^c   Ng, Erina M ^a   Whitten, Steven T ^a   Johnson III, Owen N ^a   Markham, Richard B ^d   Cone, Richard A ^a,c   Moench, Thomas R ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RAND CORPORATION   (United States)

^c REPROTECT INC   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; ANTIINFECTIVE AGENT; BUFFER; ETHIDIUM; FLUORESCENT DYE; HYDROCHLORIC ACID; SODIUM CHLORIDE;

ACIDIFICATION; ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PH; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMOBILIZATION; INFECTION PREVENTION; LEUKOCYTE MOTILITY; LYMPHOCYTE; MACROPHAGE; MICROSCOPY; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SCID MOUSE; SPERM; VAGINA; VIDEORECORDING; VIRUS TRANSMISSION; ANIMAL; DISEASE MODEL; DISEASE TRANSMISSION; DRUG EFFECT; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LEUKOCYTE; MALE; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PH; PHYSIOLOGY; TIME; VIROLOGY;

ACIDS; ANIMALS; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKOCYTES; MALE; MICE; MICE, SCID; TIME FACTORS;

EID: 27644435540     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-79     Document Type: Article

References (58)

1. Auerbach DM, Darrow WW, Jaffe HW, Curran JW: Cluster of cases of the acquired immune deficiency syndrome. Patients linked by sexual contact. Am J Med 1984, 76:487-492.
2. Chamberland ME, Castro KG, Haverkos HW, Miller BI, Thomas PA, Reiss R, Walker J, Spira TJ, Jaffe HW, Curran JW: Acquired immunodeficiency syndrome in the United States: an analysis of cases outside high-incidence groups. Ann Intern Med 1984, 101:617-623.
3. Pilcher CD, Tien HC, Eron JJ, Jr., Vernazza PL, Leu SY, Stewart PW, Goh LE, Cohen MS: Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004, 189:1785-1792.
4. Vernazza PL, Gilliam BL, Dyer J, Fiscus SA, Eron JJ, Frank AC, Cohen MS: Quantification of HIV in semen: correlation with antiviral treatment and inumme status. AIDS 1997, 11:987-993.
5. Quayle AJ, Xu C, Mayer KH, Anderson DJ: T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997, 176:960-968.
6. Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsztejn L, Heard I, Jouannet P, Sicard D, Rouzioux C: Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 1999, 13:823-831.
7. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, Evans-Strickfaden T, Bush TJ, Schnell C, Conley LJ, Clancy KA, Ellerbrock TV: Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999, 179:871-882.
8. Sodora DL, Gettie A, Miller CJ, Marx PA: Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses 1998, 14 Suppl 1:S 119-123.
9. Girard M, Mahoney J, Wei Q, van der Ryst E, Muchmore E, Barre-Sinoussi F, Fultz PN: Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1998, 14:1357-1367.
10. Burkhard MJ, Obert LA, O'Neil LL, Diehl LJ, Hoover EA: Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus. AIDS Res Hum Retroviruses 1997, 13:347-355.
11. Moench TR, Whaley KJ, Mandrell TD, Bishop BD, Witt CJ, Cone RA: The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. AIDS 1993, 7:797-802.
12. Di Fabio S, Giannini G, Lapenta C, Spada M, Binelli A, Germinario E, Sestili P, Belardelli F, Proietti E, Vella S: Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides. AIDS 2001, 15:2231-2238.
13. Khanna KV, Whaley KJ, Zeitlin L, Moench TR, Mehrazar K, Cone RA, Liao Z, Hildreth JE, Hoen TE, Shultz L, Markham RB: Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 2002, 109:205-211.
14. Ibata B, Parr EL, King NJ, Parr MB: Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes. Biol Reprod 1997, 56:537-543.
15. Zacharopoulos VR, Perotti ME, Phillips DM: A role for cell migration in the sexual transmission of HIV-1? Curr Biol 1997, 7:534-537.
16. Carreno MP, Chomont N, Kazatchkine MD, Irinopoulou T, Krief C, Mohamed AS, Andreoletti L, Matta M, Belec L: Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells. J Virol 2002, 76:32-40.
17. Boskey ER, Cone RA, Whaley KJ, Moench TR: Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 2001, 16:1809-18103.
18. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA: Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 1999, 67:5170-5175.
19. Mayer K, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg Z: Safety and tolerability of buffergel, a novel vaginal microbicide, in women in the united states. Clin Infect Dis 2001, 32:476-482.
20. Olmsted SS, Dubin NH, Cone RA, Moench TR: The rate at which human sperm are immobilized and killed by mild acidity. Fertil Steril 2000, 73:687-693.
21. Zeitlin L, Hoen TE, Achilles SL, Hegarty TA, Jerse AE, Kreider JW, Olmsted SS, Whaley KJ, Cone RA, Moench TR: Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis 2001, 28:417-423.
22. Amaral E, Faundes A, Zaneveld L, Waller D, Garg S: Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel. Contraception 1999, 60:361-366.
23. Neurath AR, Li YY, Mandeville R, Richard L: In vitro activity of a cellulose acetate phthalate topical cream against organisms associated with bacterial vaginosis. J Antimicrob Chemother 2000, 45:713-714.
24. Neurath AR, Strick N, Li YY: Water dispersible microbicidal cellulose acetate phthalate film. BMC Infect Dis 2003, 3:27.
25. Neurath AR, Strick N, Li YY, Lin K, Jiang S: Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients. Biologicals 1999, 27:11-21.
26. Meehan A, Chidanyika A, Naidoo S, Didier L, Ramjee G, Chipato T, Dinat N, Blanchard K, Team M, Padian N: Prevalence and Risk Factors for HIV Infection in Zimbabwean and South African Women: Preliminary analysis of the MIRA trial screening population. In; The XV International AIDS Conference; Bangkok, Thailand. 2004
27. Jones BM, Nicholson JK, Holman RC, Hubbard M: Comparison of monocyte separation methods using flow cytometric analysis. J Immunol Methods 1989, 125:41-47.
28. Dougherty GJ, McBride WH: Monocyte Differentiation in vitro. In Human Monocytes. Edited by Zembala M, Asherson GL. San Diego: Academic Press; 1989: 49-58
29. Hun TP: Chemotaxis of leucocytes: an improved method of direct microscopic observation. Ann Immunol (Paris) 1977, 128C:763-770.
30. Bright GR, Fisher GW, Rogowska J, Taylor DL: Fluorescence ratio imaging microscopy: temporal and spatial measurements of cytoplasmic pH. J Cell Bio 1987, 104:1019-1033.
31. Chaillet JR, Boron WF: Intracellular calibration of a pH-sensitive dye in isolated, perfused salamander proximal tubules. J Gen Physiol 1985, 86:765-794.
32. Tanasugarn L, McNeil P, Reynolds GT, Taylor DL: Microspectrofluorometry by digital image processing: measurement of cytoplasmic pH. J Cell Bio 1984, 98:717-724.
33. Thomas JA, Buchsbaum RN, Zimniak A, Racker E: Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979, 18:2210-2218.
34. Khanna KV, Whaley KJ, Zeitlin L, Ford DH, Markham RB: Vaginal transmission of HIV-1 in Hu-PBL-SCID mice. In; Poster 11215 at Twelth World AIDS Conference; Geneva, Switzerland. 1998
35. Rodbard D, Hutt DM: Statistical analysis of radioimmunoassays and immunoradiometric (labeled antibody) assays. In Symp Radioimmunoassay and Related Procedures in Clinical Medicine; Istanbul. International Atomic Energy Agency; 1973: 165-192.
36. Burghardt RC, Barhoumi R, Doolittle DJ, Philips TD: Application of Cellular Fluorescence Imaging for In Vitro Toxicology Testing. In Principles and Methods of Toxicology. 3rd edition. Edited by Hayes AW. New York: Raven Press; 1994: 1231-1258
37. Larsen B: Vaginal flora in health and disease. Clin Obstet Gynecol 1993, 36:107-121.
38. Masters W, Johnson V: The physiology of the vaginal reproductive function. Western J Surg 1961, 69:105-120.
39. Fischer B, Muller B, Fischer KG, Baur N, Kreutz W: Acidic pH inhibits non-MHC-restricted killer cell functions. Clin Immunol 2000, 96:252-263.
40. Fischer B, Muller B, Fisch P, Kreutz W: An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy. J Immunother 2000, 23:196-207.
41. Hill JA, Anderson DJ: Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am J Obstet Gynecol 1992, 166:720-726.
42. Di Fabio S, Giannini G, Spada M, Binelli A, Germinario E, Lapenta C, Carlini F, Belardelli F, Vella S: Efficacy of PRO 2000/5 Gel in a hu-SCID Mouse Model for Vaginal Transmission of Cell-associated HIV. In; Microbicides 2004; London. 2004
43. Di Fabio S, Van Roey J, Giannini G, van den Mooter G, Spada M, Binelli A, Pirillo MF, Germinario E, Belardelli F, de Bethune MP, Vella S: Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. Aids 2003, 17:1597-1604.
44. D'Cruz OJ, Samuel P, Uckun FM: PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide. Biol Reprod 2004, 71:2037-2047.
45. van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K: Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr 2001, 26:21-27.
46. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA: Microbicide Efficacy and Toxicity Tests in a Mouse Model for Vaginal Transmission of Chlamydia trachomatis. Sex Transm Dis 2002, 29:655-664.
47. Levy JA: The transmission of AIDS: the case of the infected cell. Jama 1988, 259:3037-3038.
48. Anderson DJ, Yunis EJ: "Trojan Horse" leukocytes in AIDS. N Engl J Med 1983, 309:984-985.
49. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG: Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998, 12:1699-1706.
50. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999, 180:1863-1868.
51. Tevi-Benissan C, Belec L, Levy M, Schneider-Fauveau V, Si Mohamed A, Hallouin MC, Matta M, Gresenguet G: In vivo semen-associated pH neutralization of cervicovaginal secretions. Clin Diagn Lab Immunol 1997, 4:367-374.
52. Cummins JE, Jr., Villanueva JM, Evans-Strickfaden T, Sesay SM, Abner SR, Bush TJ, Green TA, Lennox JL, Wright T, Folks TM, Hart CE, Dezzutti CS: Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method. J Clin Microbiol 2003, 41:4081-4088.
53. Grinstein S, Cohen S, Lederman HM, Gelfand EW: The intracellular pH of quiescent and proliferating human and rat thymic lymphocytes. J Cell Physiol 1984, 121:87-95.
54. Grinstein S, Cohen S, Rothstein A: Cytoplasmic pH regulation in thymic lymphocytes by an amiloride-sensitive Na+/H+ antiport. J Gen Physiol 1984, 83:341-369.
55. Swallow CJ, Grinstein S, Rotstein OD: Cytoplasmic pH regulation in macrophages by an ATP-dependent and N,N′-dicyclohexylcarbodiimide-sensitive mechanism. Possible involvement of a plasma membrane proton pump. J Biol Chem 1988, 263:19558-19563.
56. Swallow CJ, Grinstein S, Rotstein OD: Regulation of cytoplasmic pH in resident and activated peritoneal macrophages. Biochim Biophys Acta 1990, 1022:203-210.
57. Swallow C, Grinstein S, Rotstein O: Regulation and Functional Significance of Cytoplasmic pH in Phagocytic Leukocytes. In Mechanisms of leukocyte activation. Edited by Grinstein S, Rotstein O. San Diego: Academic Press; 1990: 227-247
58. Meisenholder GW, Martin SJ, Green DR, Nordberg J, Babior BM, Gottlieb RA: Events in apoptosis. Acidification is downstream of protease activation and BCL-2 protection. J Biol Chem 1996, 271:16260-16262.